Alterations in molecular status of plasma fibronectin associated with aging of normal human individuals

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 787-794

  Lemańska Perek, Anna ^a   Pupek, Małgorzata ^a   Polańska, Bozena ^a   Leszek, Jerzy ^a   Katnik Prastowska, Iwona ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aging; Fibronectin; Fibronectin domains; Fucosylation; High molecular fibronectin; Sialylation

Indexed keywords

COLLAGEN; FIBRIN; FIBRONECTIN; HEPARIN; LECTIN; MONOCLONAL ANTIBODY; SIALIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INFANT; MAACKIA; MAACKIA AMURENSIS; MALE; NEWBORN; NORMAL HUMAN; PLANT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SAMBUCUS NIGRA; SCHOOL CHILD; SENESCENCE; TETRAGONOLOBUS PURPUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CHILD; CHILD, PRESCHOOL; EPITOPES; FIBRONECTINS; FUCOSE; GLYCOSYLATION; HUMANS; INFANT, NEWBORN; LECTINS; MIDDLE AGED; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIALIC ACIDS; YOUNG ADULT;

EID: 84877818865     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.03.008     Document Type: Article

References (47)

1. To W.S., Midwood K.S. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair 2011, 4:21.
2. Cho J., Mosher D.F. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006, 4:1461-1469.
3. Maurer L.M., Tomasini-Johansson B.R., Mosher D.F. Emerging roles of fibronectin in thrombosis. Thromb Res 2010, 125:287-291.
4. Moretti F.A., Chauhan A.K., Iaconcig A., Porro F., Baralle F.E., Muro A.F. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 2007, 282:28057-28062.
5. Schwarzbauer J.E., DeSimone D.W. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol 2011, 3:1-19.
6. Martino M.M., Hubbell J.A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J 2010, 24:4711-4721.
7. Yi M., Ruoslahti E. A fibronectin fragment inhibits tumor growth angiogenesis, and metastasis. Proc Natl Acad Sci U S A 2001, 98:620-624.
8. Tajiri M., Yoshida S., Wada Y. Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment. Glycobiology 2005, 15:1332-1340.
9. Matsuura H., Greene T., Hakomori S. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J Biol Chem 1989, 264:10472-10476.
10. Katnik-Prastowska I., Orczyk-Pawiłowicz M. Expression and potential biological role of α(1,2)fucosylated glycotopes on amniotic and seminal fibronectins. Biochem Soc Trans 2011, 39:355-359.
11. Jones G.E., Arumugham R.G., Tanzer M.L. Fibronectin glycosylation modulates fibroblast adhesion and spreading. J Cell Biol 1986, 103:1663-1670.
12. Henderson B., Nair S., Pallas J., Williams M.A. Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol Rev 2011, 35:147-200.
13. Labat-Robert J. Cell-matrix interactions, the role of fibronectin and integrins. A survey. Pathol Biol 2012, 60:15-19.
14. Vakonakis I., Staunton D., Rooney L.M., Campbell I.D. Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis. EMBO J 2007, 26:2575-2583.
15. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 26:1216-1219.
16. Huveneers S., Truong H., Fässler R., Sonnenberg A., Danen E.H.J. Binding of soluble fibronectin to integrin α5β1 - link to focal adhesion redistribution and contractile shape. J Cell Sci 2008, 121:2452-2462.
17. Antia M., Baneyx G., Kubow K.E., Vogel V. Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss 2008, 139:229-249.
18. Pupek M., Lemańska-Perek A., Jasonek J., Katnik-Prastowska I. Human plasma and cerebrospinal fibronectins differ in the accessibility of the epitopes on the N-terminal domains. Acta Biochim Pol 2010, 57:333-337.
19. Klotzsch E., Smith M.L., Kubow K.E., Muntwyler S., Little W.C., Beyeler F., et al. Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. PNAS 2009, 106:18267-18272.
20. Sakata N., Sasatomi Y., Ando S., Meng J., Imanaga Y., Uesugi N., et al. Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin. Connect Tissue Res 2000, 41:117-129.
21. Labat-Robert J., Potazman J.P., Derouette J.C., Robert L. Age-dependent increase of human plasma fibronectin. Cell Biol Int Rep 1981, 5:969-973.
22. Labat-Robert J., Marques M.A., N'Doye S., Alpérovitch A., Moulias R., Allard M., et al. Plasma fibronectin in French centenarians. Arch Gerontol Geriatr 2000, 31:95-105.
23. Labat-Robert J. Cell-matrix interactions, alteration with aging and age associated diseases. Pathol Biol 2001, 49:349-352.
24. Robert L., Labat-Robert J., Robert A.M. Genetic, epigenetic and posttranslational mechanisms of aging. Biogerontology 2010, 11:387-399.
25. Phan-Thanh L., Robert L., Derouette J.C., Labat-Robert J. Increased biosynthesis and processing of fibronectin in fibroblasts from diabetic mice. Proc Natl Acad Sci U S A 1987, 84:1911-1915.
26. Bizbiz L., Labat-Robert J., Alperovitch A., Robert L. Cardiovascular determinants of plasma fibronectin in an elderly population. The EVA study. Arch Gerontol Geriatr 1997, 25:201-209.
27. Hirnle L., Katnik-Prastowska I. Amniotic fibronectin fragmentation and domain and sialyl- and fucosyl-glycotope expression associated with pregnancy complicated by intrauterine infection. Clin Chem Lab Med 2007, 45:208-214.
28. Wu A.M., Lisowska E., Duk M., Yang Z. Lectins as tools in glycoconjugate research. Glycoconj J 2009, 26:899-913.
29. Pupek M., Krzyzanowska-Gołab D., Dyła T., Lemańska-Perek A., Jankowska R., Katnik-Prastowska I. Presence of high-molecular-weight forms and domain alterations of fibronectin in pleural effusion of patients with lung cancer. Clin Biochem 2009, 42:654-661.
30. Becker D.J., Lowe J.B. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003, 13:41-53.
31. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 2009, 19:507-514.
32. Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J 2009, 26:231-245.
33. Péterszegi G., Fodil-Bourahla I., Robert A.M., Robert L. Pharmacological properties of fucose. Applications in age-related modifications of connective tissues. Biomed Pharmacother 2003, 57:240-245.
34. Ding N., Nie H., Sun X., Sun W., Qu Y., Liu X., et al. Human serum N-glycan profiles are age and sex dependent. Age Ageing 2011, 40:568-575.
35. Knežević A., Gornik O., Polašek O., Pučić M., Redžić I., Novokmet M., et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010, 20:959-969.
36. Lehmann F., Tiralongo E., Tiralongo J. Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 2006, 63:1331-1354.
37. Hampel D.J., Köttgen B., Dudenhausen J.W., Köttgen E. Fetal fibronectin as a marker for an imminent (preterm) delivery. A new technique using the glycoprotein lectin immunosorbent assay. J Immunol Methods 1999, 224:31-42.
38. Garcia G.G., Berger S.B., Akha A.A.Sadighi, Miller R.A. Age-associated changes in glycosylation of CD43 and CD45 on mouse CD4 T cells. Eur J Immunol 2005, 35:622-631.
39. Barodka V.M., Joshi B.L., Berkowitz D.E., Hogue Ch.W., Nyhan D. Implications of vascular aging. Anesth Analg 2011, 112:1048-1060.
40. Przybysz M., Borysewicz K., Szechiński J., Katnik-Prastowska I. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression. Rheumatology 2007, 46:1071-1076.
41. Briknarova K., Åkerman M.E., Hoyt D.W., Ruoslahti E., Ely K.R. Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. J Mol Biol 2003, 332:205-215.
42. Lemańska-Perek A., Leszek J., Krzyzanowska-Gołab D., Radzik J., Katnik-Prastowska I. Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk. Dement Geriatr Cogn Disord 2009, 28:338-342.
43. Toyoshima K., Kimura S., Cheng J., Oda Y., Mori K.J., Saku T. High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin. Jpn J Cancer Res 1999, 90:308-319.
44. Scher B.M., Mistry S.J., Haque N.S., Scher W. Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cells. Exp Cell Res 2010, 316:2402-2413.
45. Makogonenko E., Ingham K.C., Medved L. Interaction of the fibronectin COOH-terminal fib-2 regions with fibrin: further characterization and localization of the fib-2 binding sites. Biochemistry 2007, 8:5418-5426.
46. White E.S., Baralle F.E., Muro A.F. New insights into form and function of fibronectin splice variants. J Pathol 2008, 216:1-14.
47. Lemmon C.A., Ohashi T., Erickson H.P. Probing the folded state of fibronectin type III domains in stretched fibrils by measuring buried cysteine accessibility. J Biol Chem 2011, 286:26375-26382.